Skip to main content

Show 27 results Show all

Supportive supervision checklist for DMPA-SC self-injection programs

This checklist is a customizable tool that can be used to monitor Subcutaneous DMPA (DMPA-SC, Sayana® Press) contraceptive self-injection programs and health worker practices. The questions can be adapted as needed to align with local program designs and guidelines. To access the MS Word version of this tool in English or French, please email FPoptions@path.org.

Institutional Author(s): PATH
Publication date: August, 2020

Tool Supportive supervision checklist for DMPA-SC self-injection programs

DMPA-SC self-injection journey map for clients and health workers

This journey map was designed to help program planners with self-injection programs.

Institutional Author(s): PATH
Publication date: January, 2020

Tool DMPA-SC self-injection journey map for clients and health workers

Costs and cost-effectiveness of subcutaneous DMPA through different delivery channels: What new evidence tells us

This brief summarizes recent evidence from African countries on the costs and cost-effectiveness of DMPA-SC. Key findings include that DMPA-SC may help reduce service delivery costs by catalyzing expansion of channels closest to women and that self-injected DMPA-SC is cost-saving as compared to clinic-administered DMPA-IM when accounting for costs to women and health systems.

Institutional Author(s): PATH
Publication date: October, 2019

DMPA-SC Evidence to Practice meeting report (2019)

In 2019, the Evidence to Practice meeting provided an opportunity to sustain progress and ensure that women have access to this contraceptive innovation as quickly as possible. Delegates from 20 countries across Africa and Asia attended sessions on the state of global scale-up, self-injection evidence and best practices, family planning and HIV integration, the role of the private sector, skills building (monitoring, learning, and evaluation; commodity forecasting; and advocacy), demand generation, innovative training approaches, and a conversation with five DMPA-SC donors.

Institutional Author(s): PATH
Publication date: August, 2019

DMPA-SC self-injection supports women to use injectable contraception longer

This research brief describes research findings that women who self-inject DMPA-SC continue to use contraception longer than women who use intramuscular DMPA (DMPA-IM) administered by a health worker.

Institutional Author(s): PATH
Publication date: July, 2018

Brief DMPA-SC self-injection supports women to use injectable contraception longer

DMPA-SC self-injection job aid and reinjection calendar for clients

This visual job aid and calendar are designed for clients learning to self-injection DMPA-SC.

Institutional Author(s): PATH
Publication date: 2018

Self-Injection Feasibility and Acceptability

This brief provides an overview of PATH’s research studies assessing the feasibility and acceptability of self-injection in Uganda and Senegal.

Institutional Author(s): PATH
Publication date: January, 2018

Brief Self-Injection Feasibility and Acceptability